1. Effects of meaning training on overcoming functional fixedness
2. Roaccutane Treatment Guidelines: Results of an International Survey
3. Epidemiology of isotretinoin exposure during pregnancy
4. Dermatologic and Ophthalmic Drugs Advisory Committee. Briefing Information, 2000a. Appendix II: overview of Accutane and pregnancy exposure, September 18-19, 2000, Rockville MD: US Department of Health and Human Services, Food and Drug Administration [http://www.fda.gov/ohrms/dockets/ac/00/backgrd/3639b1.htm].
5. Dermatologic and Ophthalmic Drugs Advisory Committee. Briefing Information, 2000b. Pregnancy prevention program: a risk management program to reduce pregnancies during Accutane treatment, September 18-19, 2000, Rockville MD: US Department of Health and Human Services, Food and Drug Administration [http://www.fda.gov/ohrms/dockets/ac/00/backgrd/3639b1.htm].